Literature DB >> 3342898

Tubal factor infertility: an association with prior chlamydial infection and asymptomatic salpingitis.

J W Sellors1, J B Mahony, M A Chernesky, D J Rath.   

Abstract

In 265 Canadian women, with and without tubal factor infertility (TFI), we compared Chlamydia trachomatis cultures of endocervical swabs, endotubal swabs and biopsies, serology, and past history. A history of pelvic inflammatory disease (PID) was absent in 69.2% of TFI women, despite visual evidence of tubal damage. C. trachomatis was not isolated in any of 52 patients with TFI (TFI group), 114 having tubal ligation (STER group), or 99 patients having hysterectomy (HYST group). However, chlamydial antigen was detected with an immunochemical method in 1 of 16 tubal biopsy specimens from TFI women. The prevalence of chlamydial IgM or IgG antibody in serum was significantly higher (P less than 0.0001) in the TFI group (79.1%) than in the other two groups (relative odds, 6.3; 95% confidence interval: 2.5, 16.8). In seropositive (IgG or IgM) subjects, there was a significant (P = 0.003) and strong (relative odds, 5.1; 95% confidence interval: 1.5, 18.1) association between chlamydial IgA antibody and TFI. In women with TFI, there was no significant association between IgM or IgG seropositivity (P = 0.56). or IgA seropositivity (P = 0.53), and a negative history for PID. These findings are consistent with the hypothesis that C. trachomatis is a major cause of TFI following PID, which may or may not be asymptomatic.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3342898     DOI: 10.1016/s0015-0282(16)59772-6

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  22 in total

Review 1.  Vaginal douching: evidence for risks or benefits to women's health.

Authors:  Jenny L Martino; Sten H Vermund
Journal:  Epidemiol Rev       Date:  2002       Impact factor: 6.222

2.  Pelvic inflammatory disease: a family practice perspective.

Authors:  J W Sellors
Journal:  Can Fam Physician       Date:  1989-06       Impact factor: 3.275

3.  The association between chlamydial-specific IgG and IgA antibodies and pregnancy outcome in an in vitro fertilization program.

Authors:  E Lunenfeld; B S Shapiro; B Sarov; I Sarov; V Insler; A H Decherney
Journal:  J In Vitro Fert Embryo Transf       Date:  1989-08

4.  NOD1 in contrast to NOD2 functional polymorphism influence Chlamydia trachomatis infection and the risk of tubal factor infertility.

Authors:  Ivan Branković; Eleanne F van Ess; Marlies P Noz; Wilhelmina Anke J Wiericx; Joke Spaargaren; Servaas A Morré; Sander Ouburg
Journal:  Pathog Dis       Date:  2015-01-11       Impact factor: 3.166

5.  Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens.

Authors:  I G van Valkengoed; M J Postma; S A Morré; A J van den Brule; C J Meijer; L M Bouter; A J Boeke
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

6.  Screening for chlamydial infection. Taking stock.

Authors:  J W Sellors
Journal:  Can Fam Physician       Date:  1995-02       Impact factor: 3.275

7.  Chlamydial cervicitis: testing the practice guidelines for presumptive diagnosis.

Authors:  J Sellors; M Howard; L Pickard; D Jang; J Mahony; M Chernesky
Journal:  CMAJ       Date:  1998-01-13       Impact factor: 8.262

8.  Serologic evidence of Chlamydia trachomatis infection and risk of preterm birth.

Authors:  P Claman; B Toye; R W Peeling; P Jessamine; J Belcher
Journal:  CMAJ       Date:  1995-08-01       Impact factor: 8.262

9.  Association of the Serum Anti-chlamydial Antibodies with Tubal Infertility.

Authors:  Ashish Surana; Vijaylata Rastogi; Prem Singh Nirwan
Journal:  J Clin Diagn Res       Date:  2012-09-12

Review 10.  Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis.

Authors:  W L Beatty; R P Morrison; G I Byrne
Journal:  Microbiol Rev       Date:  1994-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.